0.34
-0.005(-1.43%)
Currency In USD
| Previous Close | 0.35 |
| Open | 0.35 |
| Day High | 0.35 |
| Day Low | 0.34 |
| 52-Week High | 1.07 |
| 52-Week Low | 0.28 |
| Volume | 815,783 |
| Average Volume | 1.81M |
| Market Cap | 78.48M |
| PE | -1.04 |
| EPS | -0.33 |
| Moving Average 50 Days | 0.51 |
| Moving Average 200 Days | 0.68 |
| Change | -0.01 |
If you invested $1000 in Vaxart, Inc. (VXRT) 10 years ago, it would be worth $13.25 as of April 19, 2025 at a share price of $0.344. Whereas If you bought $1000 worth of Vaxart, Inc. (VXRT) shares 5 years ago, it would be worth $145.11 as of April 19, 2025 at a share price of $0.344.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
GlobeNewswire Inc.
Apr 16, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vacc
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
GlobeNewswire Inc.
Apr 16, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vacc
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
GlobeNewswire Inc.
Mar 13, 2025 12:00 PM GMT
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the full year ended December 31,
Data not available